TruAlt Bioenergy Ltd (TRUALT) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039792,
    "name": "TruAlt Bioenergy",
    "stock_name": "TruAlt Bioenergy",
    "full_name": "TruAlt Bioenergy Ltd",
    "name_url": "stocks-analysis/trualt-bioenergy",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "493.40",
    "chg": -9.05,
    "chgp": "-1.8%",
    "dir": -1,
    "prev_price": "502.45",
    "mcapval": "4,325.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544545,
    "symbol": "TRUALT",
    "ind_name": "Commodity Chemicals",
    "ind_code": 11,
    "sector_id": 12,
    "indexname": "India SENSEX",
    "isin": "INE0MWH01014",
    "curr_date": "Jun 15, 03:30 PM",
    "curr_time": "00:12 AM",
    "last_traded_at": "Jun 15, 03:30 PM IST",
    "bse_nse_vol": "3.3 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 15, 2026",
    "traded_date_str": "2026 06 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/trualt-bioenergy-10039792-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "TruAlt Bioenergy Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trualt-bioenergy-ltd-is-rated-sell-4037479",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TruAltBioenergy_mojoScore_4037479.png",
        "date": "2026-06-07 10:10:20",
        "description": "TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "TruAlt Bioenergy Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trualt-bioenergy-ltd-is-rated-sell-4037485",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TruAltBioenergy_mojoScore_4037485.png",
        "date": "2026-06-06 10:10:19",
        "description": "TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "TruAlt Bioenergy Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trualt-bioenergy-ltd-is-rated-sell-4037499",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TruAltBioenergy_mojoScore_4037499.png",
        "date": "2026-06-05 10:10:20",
        "description": "TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "TruAlt Bioenergy Ltd Valuation Shifts to Fair Amidst Strong Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trualt-bioenergy-ltd-valuation-shifts-to-fair-amidst-strong-market-returns-4032868",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TruAltBioenergy_valuationdot_4032868.png",
        "date": "2026-06-03 08:03:12",
        "description": "TruAlt Bioenergy Ltd, a small-cap player in the commodity chemicals sector, has seen its valuation grade move from attractive to fair, reflecting a notable shift in market perception. Despite a strong year-to-date return of 25.6%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now align more closely with sector averages, prompting a reassessment of its price attractiveness relative to peers and historical benchmarks."
      },
      {
        "title": "TruAlt Bioenergy Ltd Hits Intraday Low Amid Price Pressure on 25 May 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trualt-bioenergy-ltd-hits-intraday-low-amid-price-pressure-on-25-may-2026-4010391",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/TruAltBioenergy_priceRelatedfactors_4010391.png",
        "date": "2026-05-25 10:26:33",
        "description": "TruAlt Bioenergy Ltd experienced a notable decline in intraday trading on 25 May 2026, touching a low of Rs 420, marking a 15.15% drop from previous levels. The stock’s performance today was marked by significant price pressure, underperforming its sector and broader market indices despite a positive trend in the Sensex."
      },
      {
        "title": "TruAlt Bioenergy Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trualt-bioenergy-ltd-is-rated-sell-by-marketsmojo-4010291",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/TruAltBioenergy_mojoScore_4010291.png",
        "date": "2026-05-25 10:10:25",
        "description": "TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 25 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Are TruAlt Bioenergy Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-trualt-bioenergy-ltd-latest-results-good-or-bad-4009014",
        "imagepath": "",
        "date": "2026-05-23 19:26:46",
        "description": "TruAlt Bioenergy Ltd's latest financial results for Q4 FY26 present a complex picture of operational performance. The company reported net sales of ₹595.52 crores, reflecting a year-on-year decline of 34.34% from ₹906.99 crores in Q4 FY25. However, this figure indicates a recovery from the significantly lower revenue of ₹114.86 crores in Q3 FY26, suggesting some stabilization in sales despite the ongoing volatility. The quarter-on-quarter revenue contraction was recorded at 16.50%, which follows a dramatic 62.20% decline in the previous quarter.\n\nNet profit for the quarter stood at ₹59.88 crores, which is a 46.39% decrease compared to the same quarter last year, and a 13.63% drop from the prior quarter. This decline in net profit occurred despite an improvement in the operating margin, which reached 19.94%, up from 16.95% in Q4 FY25. However, the profit after tax (PAT) margin contracted to 10.23%, down from..."
      },
      {
        "title": "TruAlt Bioenergy Q4 FY26: Profit Plunges 46% Despite Revenue Recovery",
        "link": "https://www.marketsmojo.com/news/result-analysis/trualt-bioenergy-q4-fy26-profit-plunges-46-despite-revenue-recovery-4008518",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/TruAltBioenergy_quaterlyResult_4008518.png",
        "date": "2026-05-23 11:49:59",
        "description": "TruAlt Bioenergy Ltd., a small-cap commodity chemicals manufacturer with a market capitalisation of ₹4,145 crores, posted a consolidated net profit of ₹59.88 crores for Q4 FY26, marking a sharp 46.39% year-on-year decline from ₹111.69 crores in Q4 FY25. The quarterly results reveal a company grappling with margin compression and operational volatility despite sequential revenue improvement, raising concerns about earnings quality and sustainability."
      },
      {
        "title": "TruAlt Bioenergy Ltd Valuation Shifts: From Attractive to Fair Amid Sector Comparisons",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trualt-bioenergy-ltd-valuation-shifts-from-attractive-to-fair-amid-sector-comparisons-4004293",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/TruAltBioenergy_valuationdot_4004293.png",
        "date": "2026-05-22 08:01:41",
        "description": "TruAlt Bioenergy Ltd, a small-cap player in the Commodity Chemicals sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid rising price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the stock differently against its peers and historical benchmarks."
      }
    ],
    "total": 78,
    "sid": "10039792",
    "stock_news_url": "https://www.marketsmojo.com/news/trualt-bioenergy-10039792"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-Jun-2026",
      "details": "The Company has published the newspaper advertisement regarding the Postal Ballot Notice in Financial Express and Vishwavani on June 09 2026.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "08-Jun-2026",
      "details": "The Company has issued the Postal Ballot Notice through remote E-voting for the approval of the Material Related Party Transaction.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Jun-2026",
      "details": "TruAlt Bioenergy Limited has informed the Exchange about Schedule of analyst/ Institutional Investors meet.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

TruAlt Bioenergy Ltd is Rated Sell

2026-06-07 10:10:20

TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

TruAlt Bioenergy Ltd is Rated Sell

2026-06-06 10:10:19

TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

TruAlt Bioenergy Ltd is Rated Sell

2026-06-05 10:10:20

TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

TruAlt Bioenergy Ltd Valuation Shifts to Fair Amidst Strong Market Returns

2026-06-03 08:03:12

TruAlt Bioenergy Ltd, a small-cap player in the commodity chemicals sector, has seen its valuation grade move from attractive to fair, reflecting a notable shift in market perception. Despite a strong year-to-date return of 25.6%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now align more closely with sector averages, prompting a reassessment of its price attractiveness relative to peers and historical benchmarks.

Read full news article

TruAlt Bioenergy Ltd Hits Intraday Low Amid Price Pressure on 25 May 2026

2026-05-25 10:26:33

TruAlt Bioenergy Ltd experienced a notable decline in intraday trading on 25 May 2026, touching a low of Rs 420, marking a 15.15% drop from previous levels. The stock’s performance today was marked by significant price pressure, underperforming its sector and broader market indices despite a positive trend in the Sensex.

Read full news article

TruAlt Bioenergy Ltd is Rated Sell by MarketsMOJO

2026-05-25 10:10:25

TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 25 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Are TruAlt Bioenergy Ltd latest results good or bad?

2026-05-23 19:26:46

TruAlt Bioenergy Ltd's latest financial results for Q4 FY26 present a complex picture of operational performance. The company reported net sales of ₹595.52 crores, reflecting a year-on-year decline of 34.34% from ₹906.99 crores in Q4 FY25. However, this figure indicates a recovery from the significantly lower revenue of ₹114.86 crores in Q3 FY26, suggesting some stabilization in sales despite the ongoing volatility. The quarter-on-quarter revenue contraction was recorded at 16.50%, which follows a dramatic 62.20% decline in the previous quarter. Net profit for the quarter stood at ₹59.88 crores, which is a 46.39% decrease compared to the same quarter last year, and a 13.63% drop from the prior quarter. This decline in net profit occurred despite an improvement in the operating margin, which reached 19.94%, up from 16.95% in Q4 FY25. However, the profit after tax (PAT) margin contracted to 10.23%, down from...

Read full news article

TruAlt Bioenergy Q4 FY26: Profit Plunges 46% Despite Revenue Recovery

2026-05-23 11:49:59

TruAlt Bioenergy Ltd., a small-cap commodity chemicals manufacturer with a market capitalisation of ₹4,145 crores, posted a consolidated net profit of ₹59.88 crores for Q4 FY26, marking a sharp 46.39% year-on-year decline from ₹111.69 crores in Q4 FY25. The quarterly results reveal a company grappling with margin compression and operational volatility despite sequential revenue improvement, raising concerns about earnings quality and sustainability.

Read full news article

TruAlt Bioenergy Ltd Valuation Shifts: From Attractive to Fair Amid Sector Comparisons

2026-05-22 08:01:41

TruAlt Bioenergy Ltd, a small-cap player in the Commodity Chemicals sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid rising price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the stock differently against its peers and historical benchmarks.

Read full news article

View All News